Christopher Vaughan

Clinical Professor

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Vaughan is a Clinical Professor at the University of Sydney, Australia. His research primarily focuses on the effects of cannabinoids and opioids in pain management, with recent articles exploring topics such as chronic neuropathic pain, synaptic plasticity, and analgesic pathways. His work contributes to understanding the clinical applications of cannabis constituents in treating pain and involves both animal models and clinical evidence.

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Bryce Vissel

Professor of Neuroscience and Head

AUSTRALIA

View details

Amanda Wright

Macquarie University

AUSTRALIA

View details

Bryony Winters

Lecturer

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Vaughan

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Preface to the special issue “Pain”

Disrupted stress‐induced analgesia in a neuropathic pain state is rescued by the endocannabinoid degradation inhibitor JZL195

Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

Cannabinoids and Opioids Differentially Target Extrinsic and Intrinsic GABAergic Inputs onto the Periaqueductal Grey Descending Pathway

Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model

Mechanisms of endocannabinoid control of synaptic plasticity

Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.

A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability

The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrations.

Inflammation induces developmentally regulated sumatriptan inhibition of spinal synaptic transmission

Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway

Collaborators (3)

Bryce Vissel

Amanda Wright

Bryony Winters

Make your next move.